Benzyl Isothiocyanate (CAS 622-78-6): Research Evidence and Sourcing

Benzyl isothiocyanate (BITC; CAS 622-78-6) is an isothiocyanate identified in PubChem, CID 2346, with molecular formula C₈H₇NS. It is relevant to chemical analysis and experimental research. A study describing biological activity must be interpreted within its experimental setting.

Identity and sourcing checks

Use the exact chemical identifier when comparing records. Benzyl isothiocyanate, phenethyl isothiocyanate and other isothiocyanates are different substances. A result obtained with one substance or preparation cannot automatically be transferred to another.

What the cancer research actually studied

The published literature includes experiments in cultured cancer cells and animal models. For example, a 2009 study by Warin and colleagues evaluated BITC in a mouse model of mammary carcinogenesis. a 2011 study by Kim and colleagues examined tumor growth and metastasis in mice implanted with murine mammary carcinoma cells.

Those experiments support further investigation in the models studied. They do not establish that taking BITC prevents or treats cancer in people, and they do not establish a safe human dose. An absence of a particular adverse effect measured in an animal experiment is not evidence that a compound is free of side effects in humans.

How to evaluate a research claim

• Model: identify whether the work used a cell line, an animal model or human participants.
• Material: check compound identity, purity, solvent, formulation and analytical characterization.
• Exposure: distinguish an experimental concentration or animal exposure from a clinical dosing instruction.
• Outcome: identify what was measured. A molecular signal or change in cell viability is not automatically a demonstrated patient benefit.
• Limitations: review controls, sample size, adverse effects, replication, corrections and the authors’ stated limitations.

Food and regulatory claims need separate evidence

The occurrence of a related compound in food, or a research paper about it, does not authorize unrestricted use of concentrated BITC in food, supplements, cosmetics or medicines. Any proposed application needs a current assessment of the exact substance, formulation, permitted conditions and destination market. A database entry or industry identifier should not be described as blanket FDA approval.

Product documentation and handling

The Longchang product record is a starting point for an inquiry. Request confirmation of material form, current assay and impurity limits, storage conditions, packaging and transport classification. Historical catalog statements require verification against the current supplier documents.

Handling procedures must follow the SDS for the actual material and the risk assessment for the intended work. Do not use a research chemical or supplier sample for self-medication. For personal health questions, consult a qualified healthcare professional.

Questions for a useful quotation

Provide the chemical name and CAS number, desired grade, required quantity, intended professional use, destination country and documents needed for evaluation. Where your process requires a solution, specify the solvent and concentration. Confirm how assay, water, impurities and other acceptance criteria will be measured before comparing offers.

Reviewed and corrected: 10 September 2026. This revision replaces claims of human cancer prevention and broad safety or approval with identified preclinical evidence and its limitations. It does not provide clinical advice.